RBM5 and pancreatic neoplasm: As shown in the table, underexpression of RBM5 in pancreatic cancers was found to be significantly associated with lymph node metastasis, distant metastasis, Union for International Cancer Control (UICC) stage and nerve and venous invasion (P<0.05).